Clinical trial
A Multicenter Randomized Controlled Clinical Study on the Treatment of T3N1M0 High Risk Nasopharyngeal Carcinoma With or Without Induction Chemotherapy Before Concurrent Radiotherapy and Chemotherapy
NCT05622474 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Randomized Controlled Clinical Study on the Treatment of T3N1M0 High Risk Nasopharyngeal Carcinoma With or Without Induction Chemotherapy Before Concurrent Radiotherapy and Chemotherapy
- Lead sponsor
- Sun Yat-sen University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- November 30, 2022
- Completion date
- December 31, 2028
- Enrollment
- 236 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.